No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)

No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study)

BackgroundUnderstanding the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination will enable accurate counseling and inform evolving vaccination strategies. Little is known about antibody response following booster vaccination in people living with HIV (PLWH).M...

Full description

Bibliographic Details
Main Authors: Kendall D. Kling, Patrick Janulis, Alexis R. Demonbreun, Amelia Sancilio, Baiba Berzins, Karen Krueger, Chad Achenbach, Rachelle Price, Margaret Sullivan, Matthew Caputo, Sara Hockney, Teresa Zembower, Thomas W. McDade, Babafemi Taiwo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2 antibody
neutralization
SARS-COV-2 vaccination
HIV
booster vaccines
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1048776/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1048776/full

Similar Items